-+ 0.00%
-+ 0.00%
-+ 0.00%

PASSAGE BIO INC - EXPECTS AGGREGATE SEVERANCE AND EXIT COSTS OF $3.3 MLN - SEC FILING

Reuters·04/28/2026 11:18:41

Please log in to view news